27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
(Biotech stocks hitting 52-week highs on Aug. 26)
- DURECT Corporation (NASDAQ:DRRX)
- Stoke Therapeutics Inc (NASDAQ:STOK)
Down In The Dumps
(Biotech stocks hitting 52-week lows on Aug. 26)
- Advaxis, Inc. (NASDAQ:ADXS)
- Arbutus Biopharma Corp (NASDAQ:ABUS)
- ASLAN PHARMACEU/ADR (NASDAQ:ASLN)
- Avanos Medical Inc (NYSE:AVNS)
- Cancer Genetics Inc (NASDAQ:CGIX)
- Clearside Biomedical Inc (NASDAQ:CLSD)
- Elanco Animal Health Inc (NYSE:ELAN)(Bank of America downgraded the shares to Neutral)
- Neurometrix Inc (NASDAQ:NURO)
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN)
- Stealth BioTherapeutics Corp (NASDAQ:MITO)
- Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH)
- Tocagen Inc (NASDAQ:TOCA)
- Unity Biotechnology Inc (NASDAQ:UBX)
- Zafgen Inc (NASDAQ:ZFGN)
Stocks In Focus
Nuvectra To Explore Strategic Options
Nuvectra Corp (NASDAQ:NVTR) announced its decision to explore strategic alternatives to enhance shareholder value, including a sale or merger of the company. The company said the step has been necessitated by the need of financing for the expected growth of its business.
"As we go through this process, we remain committed to providing physicians with world-class neurostimulation technology that improves the lives of patients and to assisting them in supporting their patients," the company said in a release.
The stock jumped 41.96% to $2.03 in after-hours trading.
Want Private Access to Benzinga Analyst?
Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.
Alcon Announces Commercial Launch Of First FDA-Approved Trifocal Lens
Alcon AG (NYSE:ALC) said the FDA approved its AcrySof IQ PanOptix trifocal intraocular lens, or IOL, the first and only trifocal lens for U.S. patients undergoing cataract surgery.
The company noted that PanOptix delivers an exceptional combination of near, intermediate and distance vision, while significantly reducing the need for glasses after surgery.
The company intends to begin training U.S. ophthalmologists and making inventory of both PanOptix and PanOptix Tonic IOLs available through the rest of 2019 into early 2020.
The stock rose 1.57% to $59.48 in after-hours trading.
J&J To Contend Cleveland's $572M Opioid Lawsuit Ruling
Johnson & Johnson (NYSE:JNJ) and its Janssen unit said they will appeal the $572 million civil judgment entered in Cleveland County District Court in the State of Oklahoma's lawsuit against opioid manufacturers.
The company sees strong grounds to appeal the decision, as it has complied with the federal and state laws, its medicines play an unique role in the lives of people in need of them and its responsible marketing practices.
Also, the company noted that since launch, its opioid medications Duragesic, Nucynta and Nucynta ET accounted for less than 1% of total opioid prescriptions in Oklahoma as well as the U.S.
The stock rose 2.31% to $130.75 in after-hours trading.
Sesen Bio Appoints Company Veteran Monica Forbes As CFO
Sesen Bio Inc (NASDAQ:SESN) announced the appointment of company veteran Monica Forbes as CFO, effective immediately, as she succeeds Richard Fitzgerald, who is leaving the company, effective Aug. 30. The company also announced the appointment of Kristin Anderson as Principal Accounting Officer.
The stock gained 2.65% to $1.16 in after-hours trading.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.